Sector

All

Cyber

Digital Biology

Alternative

Energy

Other

Location

All

Americas

EMEA

APAC

Rest of World

Home > Portfolio > Cellsonics

Location:

San Jose, CA, USA

Initial Investment Date:

August 2021

Investment Status:

Current

Next generation single cell isolation

The Cellsonics platform was developed to build a novel approach to tissue disassociation using bulk lateral ultrasonic (BLU) vibrations to create precise shear stress patterns within tissue solutions, gently separating cells mechanically vs use of harsh digestive enzymes. The BLU technique improves sample fidelity and reduces genomic and biochemical changes within samples during this sample prep step.